|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for PLCB1 |
Basic gene info. | Gene symbol | PLCB1 |
Gene name | phospholipase C, beta 1 (phosphoinositide-specific) | |
Synonyms | EIEE12|PI-PLC|PLC-154|PLC-I|PLC154|PLCB1A|PLCB1B | |
Cytomap | UCSC genome browser: 20p12 | |
Genomic location | chr20 :8113295-8865547 | |
Type of gene | protein-coding | |
RefGenes | NM_015192.3, NM_182734.2, | |
Ensembl id | ENSG00000182621 | |
Description | 1-phosphatidyl-D-myo-inositol-4,5-bisphosphate1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1PLC-beta-1inositoltrisphosphohydrolasemonophosphatidylinositol phosphodiesterasephosphoinositidase Cphospholipase C-Itriphosphoinositide p | |
Modification date | 20141222 | |
dbXrefs | MIM : 607120 | |
HGNC : HGNC | ||
Ensembl : ENSG00000182621 | ||
HPRD : 06177 | ||
Vega : OTTHUMG00000031849 | ||
Protein | UniProt: Q9NQ66 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_PLCB1 | |
BioGPS: 23236 | ||
Gene Expression Atlas: ENSG00000182621 | ||
The Human Protein Atlas: ENSG00000182621 | ||
Pathway | NCI Pathway Interaction Database: PLCB1 | |
KEGG: PLCB1 | ||
REACTOME: PLCB1 | ||
ConsensusPathDB | ||
Pathway Commons: PLCB1 | ||
Metabolism | MetaCyc: PLCB1 | |
HUMANCyc: PLCB1 | ||
Regulation | Ensembl's Regulation: ENSG00000182621 | |
miRBase: chr20 :8,113,295-8,865,547 | ||
TargetScan: NM_015192 | ||
cisRED: ENSG00000182621 | ||
Context | iHOP: PLCB1 | |
cancer metabolism search in PubMed: PLCB1 | ||
UCL Cancer Institute: PLCB1 | ||
Assigned class in ccmGDB | B - This gene belongs to cancer gene. |
Top |
Phenotypic Information for PLCB1(metabolism pathway, cancer, disease, phenome) |
Cancer Description | |
Cancer | CGAP: PLCB1 |
Familial Cancer Database: PLCB1 |
* This gene is included in those cancer gene databases. |
. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
Metabolic Pathway Description | |
KEGG_INOSITOL_PHOSPHATE_METABOLISM REACTOME_INTEGRATION_OF_ENERGY_METABOLISM |
Others | |
OMIM | 607120; gene. 607120; gene. 613722; phenotype. 613722; phenotype. |
Orphanet | 293181; Malignant migrating partial seizures of infancy. 293181; Malignant migrating partial seizures of infancy. 3451; West syndrome. 3451; West syndrome. |
Disease | KEGG Disease: PLCB1 |
MedGen: PLCB1 (Human Medical Genetics with Condition) | |
ClinVar: PLCB1 | |
Phenotype | MGI: PLCB1 (International Mouse Phenotyping Consortium) |
PhenomicDB: PLCB1 |
Mutations for PLCB1 |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
Structural Variants in COSMIC: go to COSMIC mutation histogram |
- Statistics for Tissue and Mutation type | Top |
- For Inter-chromosomal Variations |
* Inter-chromosomal variantions includes 'interchromosomal amplicon to amplicon', 'interchromosomal amplicon to non-amplified dna', 'interchromosomal insertion', 'Interchromosomal unknown type'. |
- For Intra-chromosomal Variations |
* Intra-chromosomal variantions includes 'intrachromosomal amplicon to amplicon', 'intrachromosomal amplicon to non-amplified dna', 'intrachromosomal deletion', 'intrachromosomal fold-back inversion', 'intrachromosomal inversion', 'intrachromosomal tandem duplication', 'Intrachromosomal unknown type', 'intrachromosomal with inverted orientation', 'intrachromosomal with non-inverted orientation'. |
Sample | Symbol_a | Chr_a | Start_a | End_a | Symbol_b | Chr_b | Start_b | End_b |
breast | PLCB1 | chr20 | 8296860 | 8296860 | PLCB1 | chr20 | 8357007 | 8357007 |
large_intestine | PLCB1 | chr20 | 8810913 | 8810913 | chr20 | 8882215 | 8882215 | |
ovary | PLCB1 | chr20 | 8608069 | 8608089 | PLCB1 | chr20 | 8646243 | 8646263 |
ovary | PLCB1 | chr20 | 8625349 | 8625369 | PLCB1 | chr20 | 8614037 | 8614057 |
ovary | PLCB1 | chr20 | 8630133 | 8630333 | CDKAL1 | chr6 | 20668965 | 20669165 |
ovary | PLCB1 | chr20 | 8757588 | 8757608 | PLCB1 | chr20 | 8735524 | 8735544 |
pancreas | PLCB1 | chr20 | 8357110 | 8357130 | chr20 | 56389979 | 56389999 | |
pancreas | PLCB1 | chr20 | 8469553 | 8469573 | PLCB1 | chr20 | 8534994 | 8535014 |
pancreas | PLCB1 | chr20 | 8636339 | 8636359 | PLCB1 | chr20 | 8774028 | 8774048 |
pancreas | PLCB1 | chr20 | 8726325 | 8726345 | ZNF335 | chr20 | 44589603 | 44589623 |
pancreas | PLCB1 | chr20 | 8726326 | 8726346 | ZNF335 | chr20 | 44589603 | 44589623 |
cf) Tissue number; Tissue name (1;Breast, 2;Central_nervous_system, 3;Haematopoietic_and_lymphoid_tissue, 4;Large_intestine, 5;Liver, 6;Lung, 7;Ovary, 8;Pancreas, 9;Prostate, 10;Skin, 11;Soft_tissue, 12;Upper_aerodigestive_tract) |
Related fusion transcripts : go to Chitars2.0 |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows PLCB1 related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
AA984410 | PLCB1 | 1 | 232 | 20 | 8630065 | 8639283 | NLGN2 | 232 | 251 | 17 | 7320966 | 7320985 | |
BE835662 | PLCB1 | 4 | 266 | 20 | 8188789 | 8189060 | GTF2A1 | 265 | 366 | 14 | 81686939 | 81687040 | |
BF954088 | ZSWIM4 | 149 | 176 | 19 | 13929041 | 13929072 | PLCB1 | 176 | 195 | 20 | 8226543 | 8226562 | |
CV383659 | PLCB1 | 7 | 69 | 20 | 8629223 | 8629285 | PLCB1 | 64 | 317 | 20 | 8618801 | 8619050 |
Other DBs for Structural Variants |
Top |
Copy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr |
Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
Total # sample | 9 | 2 |   | 2 |   |   | 8 |   | 10 |   | 5 |   |   |   | 5 | 1 | 3 | |||
GAIN (# sample) | 8 | 2 |   | 1 |   |   | 6 |   | 10 |   | 5 |   |   |   | 5 | 1 | 3 | |||
LOSS (# sample) | 1 |   |   | 1 |   |   | 2 |   |   |   |   |   |   |   |   |   |   |
cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
Top |
SNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation |
|
Top |
Somatic Mutation Counts per Tissue in COSMIC data |
Stat. for Non-Synonymous SNVs (# total SNVs=155) | (# total SNVs=58) |
(# total SNVs=3) | (# total SNVs=0) |
Top |
Top 10 SNVs Having the Most Samples in COSMIC data |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr20:8862337-8862337 | p.F1164L | 5 |
chr20:8628584-8628584 | p.R168C | 4 |
chr20:8755294-8755294 | p.Q1013H | 4 |
chr20:8862495-8862495 | p.*1217* | 4 |
chr20:8719917-8719917 | p.P740S | 4 |
chr20:8755243-8755243 | p.A996A | 3 |
chr20:8769133-8769133 | p.Q1050R | 3 |
chr20:8665694-8665694 | p.F326L | 3 |
chr20:8665706-8665706 | p.S330S | 3 |
chr20:8689378-8689378 | p.S410L | 3 |
Top |
SNV Counts per Each Loci in TCGA data |
|
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample | 5 | 4 |   | 30 | 1 |   | 14 | 1 | 2 | 2 |   | 39 | 13 | 6 | 1 | 1 | 43 | 18 |   | 15 |
# mutation | 5 | 4 |   | 28 | 1 |   | 14 | 1 | 2 | 2 |   | 42 | 14 | 6 | 1 | 1 | 62 | 21 |   | 14 |
nonsynonymous SNV | 4 | 3 |   | 18 |   |   | 12 | 1 |   | 2 |   | 34 | 9 | 6 |   |   | 43 | 13 |   | 7 |
synonymous SNV | 1 | 1 |   | 10 | 1 |   | 2 |   | 2 |   |   | 8 | 5 |   | 1 | 1 | 19 | 8 |   | 8 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
Top 10 SNVs Having the Most Samples in TCGA data |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr20:8862337 | p.F1164F | 5 |
chr20:8689378 | p.Q1050R,PLCB1 | 3 |
chr20:8769133 | p.S410L,PLCB1 | 3 |
chr20:8630054 | p.R168C,PLCB1 | 2 |
chr20:8862318 | p.P1158H | 2 |
chr20:8665694 | p.Q253Q,PLCB1 | 2 |
chr20:8639248 | p.S454R,PLCB1 | 2 |
chr20:8665706 | p.R182W,PLCB1 | 2 |
chr20:8698344 | p.H866N,PLCB1 | 2 |
chr20:8678311 | p.G367E,PLCB1 | 2 |
Other DBs for Point Mutations |
Copy Number for PLCB1 in TCGA |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for PLCB1 |
Gene Expression in Cancer Cell-lines (CCLE) |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
Differential Gene Expression in Primary Tumors (TCGA) |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
Top |
CNV vs Gene Expression Plot |
* This plots show the correlation between CNV and gene expression. |
Top |
Gene-Gene Network Information |
Co-Expressed gene's network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
ANKRD50,ATRN,BMPR2,BTBD3,SLX4IP,C2orf50,CSNK2A3, EPS8,FRRS1,HOMER1,HUNK,TTI1,NR3C2,OCLN, PLCB1,POU6F2,RALGAPB,RNF24,RPRD1B,TMX4,TOP1 | BCLAF1,EPM2AIP1,ESCO1,GOSR1,KDM6A,KRR1,MAP3K7, NAA25,PLCB1,PRPF40A,PUM1,SCAF8,RBM27,RPS6KA5, SMARCAD1,SMC5,SP4,THOC2,USP37,WAPAL,ZNF644 | ||||
ANKEF1,TMEM230,SLX4IP,CDS2,CSNK2A1,ESF1,FGF13, KIF16B,MAVS,PANK2,PLCB1,PSMF1,PTPRA,RIN2, TASP1,TBC1D20,TMX4,TRMT6,UBOX5,VPS16,ZCCHC3 | C16orf45,FAXC,CLIP4,DIXDC1,DPYSL3,DZIP1,EHBP1, EPM2A,GPM6A,NECAB1,NEGR1,PLCB1,RAB11FIP2,RBPMS2, RHOJ,SCD5,SDPR,SMARCA1,SPARCL1,STON1,ZAK |
Co-Expressed gene's Protein-protein interaction Network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
Interacting Genes (from Pathway Commons) |
Top |
Pharmacological Information for PLCB1 |
Cross-referenced pharmacological DB IDs from Uniprot |
DB Category | DB Name | DB's ID and Url link |
Chemistry | BindingDB | Q9NQ66; -. |
Chemistry | ChEMBL | CHEMBL4034; -. |
Chemistry | BindingDB | Q9NQ66; -. |
Chemistry | ChEMBL | CHEMBL4034; -. |
Organism-specific databases | PharmGKB | PA33384; -. |
Organism-specific databases | PharmGKB | PA33384; -. |
Organism-specific databases | CTD | 23236; -. |
Organism-specific databases | CTD | 23236; -. |
Drug-Gene Interaction Network |
* Gene Centered Interaction Network. |
* Drug Centered Interaction Network. |
DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
DB00945 | phospholipase C, beta 1 (phosphoinositide-specific) | approved | Acetylsalicylic acid | ||
DB00125 | phospholipase C, beta 1 (phosphoinositide-specific) | approved; nutraceutical | L-Arginine | ||
DB00435 | phospholipase C, beta 1 (phosphoinositide-specific) | approved | Nitric Oxide | ||
DB00171 | phospholipase C, beta 1 (phosphoinositide-specific) | approved; nutraceutical | Adenosine triphosphate | ||
DB00988 | phospholipase C, beta 1 (phosphoinositide-specific) | approved | Dopamine | ||
DB00917 | phospholipase C, beta 1 (phosphoinositide-specific) | approved | Dinoprostone | ||
DB01240 | phospholipase C, beta 1 (phosphoinositide-specific) | approved | Epoprostenol | ||
DB01115 | phospholipase C, beta 1 (phosphoinositide-specific) | approved | Nifedipine |
Top |
Cross referenced IDs for PLCB1 |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |